#ASH22: Lil­ly’s Loxo spells out BTK da­ta as it eyes BeiGene, Ab­b­Vie/J&J and As­traZeneca

NEW OR­LEANS — Eli Lil­ly’s Loxo On­col­o­gy unit showed up at this year’s Amer­i­can So­ci­ety of Hema­tol­ogy con­fer­ence with da­ta in mul­ti­ple sub­sets of pa­tients …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER